Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Stoll

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Chemical Biology|February 6, 2002
Miniaturised multiplexed immunoassaysThomas O Joos, Dieter Stoll, Markus F Templin
Acta Neuropsychiatrica|March 18, 2016
Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depressionHans-Jürgen Möller, Hans-Peter Volz, Klaus-Dieter Stoll
Current Opinion in Drug Discovery & Development|March 24, 2005
Protein microarrays: applications and future challengesDieter Stoll, Markus F Templin, Jutta Bachmann, et al.
Combinatorial Chemistry & High Throughput Screening|May 12, 2004
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?Markus F Templin, Dieter Stoll, Jutta Bachmann, et al.
Drug Discovery Today|April 12, 2013
Microarray technology: an increasing variety of screening tools for proteomic researchDieter Stoll, Jutta Bachmann, Markus F Templin, et al.
Biotechniques|January 8, 2003
Cell microarrays: an emerging technology for the characterization of antibodiesJochen M Schwenk, Dieter Stoll, Markus F Templin, et al.
Analytical and Bioanalytical Chemistry|September 23, 2008
Protein microarrays for diagnostic assaysMichael Hartmann, Johan Roeraade, Dieter Stoll, et al.
Proteomics|March 19, 2009
Proteome wide screening using peptide affinity captureOliver Poetz, Sibylle Hoeppe, Markus F Templin, et al.
Neuropsychobiology|May 18, 2011
Opipramol improves subjective quality of sleep the night prior to surgery: confirmatory testing of a double-blind, randomized clinical trialMichael Hueppe, David Hartge, Klaus-Dieter Stoll, et al.
Proteomics|June 19, 2012
Five years later: the current status of the use of proteomics and transcriptomics in EMF researchDariusz Leszczynski, David de Pomerai, Dirk Koczan, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Chemical Biology|February 6, 2002
Miniaturised multiplexed immunoassaysThomas O Joos, Dieter Stoll, Markus F Templin
Acta Neuropsychiatrica|March 18, 2016
Psychopharmacotherapy of somatoform disorders: effects of opipramol on symptoms of somatization, anxiety, and depressionHans-Jürgen Möller, Hans-Peter Volz, Klaus-Dieter Stoll
Current Opinion in Drug Discovery & Development|March 24, 2005
Protein microarrays: applications and future challengesDieter Stoll, Markus F Templin, Jutta Bachmann, et al.
Combinatorial Chemistry & High Throughput Screening|May 12, 2004
Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?Markus F Templin, Dieter Stoll, Jutta Bachmann, et al.
Drug Discovery Today|April 12, 2013
Microarray technology: an increasing variety of screening tools for proteomic researchDieter Stoll, Jutta Bachmann, Markus F Templin, et al.
Biotechniques|January 8, 2003
Cell microarrays: an emerging technology for the characterization of antibodiesJochen M Schwenk, Dieter Stoll, Markus F Templin, et al.
Analytical and Bioanalytical Chemistry|September 23, 2008
Protein microarrays for diagnostic assaysMichael Hartmann, Johan Roeraade, Dieter Stoll, et al.
Proteomics|March 19, 2009
Proteome wide screening using peptide affinity captureOliver Poetz, Sibylle Hoeppe, Markus F Templin, et al.
Neuropsychobiology|May 18, 2011
Opipramol improves subjective quality of sleep the night prior to surgery: confirmatory testing of a double-blind, randomized clinical trialMichael Hueppe, David Hartge, Klaus-Dieter Stoll, et al.
Proteomics|June 19, 2012
Five years later: the current status of the use of proteomics and transcriptomics in EMF researchDariusz Leszczynski, David de Pomerai, Dirk Koczan, et al.
Pageof 4